Blueberries Medical Corp.

Management team

Christian Toro

Christian Toro

Chairman and Chief Executive Officer
40+ years of experience. Mr. Toro began his professional career at Publicidad Toro in 1978, a leading Colombian marketing and advertising firm where he was appointed Chief Executive Officer in 1982. Mr. Toro is also the founder of Manning Selvage & Lee, a public relations firm, and Arena, a media buying company. Mr. Toro has worked in advertising and marketing for the National Coffee Growers Association in Colombia for more than 25 years. He is a university professor and reputation consultant for presidents, senators and other politicians. He is also a member of the board of directors of Corporación Matamoros (the Ministry of National Defense of Colombia).        

Ian D. Atacan CPA, CMA

Chief Financial Officer
Mr. Atacan is a finance leader with more than 25 years of experience in business strategy development, valuations of M&A, debt and equity financing, divestitures and investment transactions, financial modeling, project management, competitive analysis and developing strategic investment recommendations. He has worked with renowned international companies such as Sprint, DHL Worldwide Express, and Procter & Gamble. Most recently, Mr. Atacan was the Chief Financial Officer of Natura Naturals Holdings Inc., a Canadian cannabis company licensed for cultivation, production and bulk sales under the Cannabis Act of Canada, until its acquisition by Tilray Inc. (NASDAQ: TLRY) for $82 million. As Chief Financial Officer of Blueberries, Mr. Atacan brings entrepreneurial and financial acumen cultivated through business start-ups, recapitalizations, and expansion projects to drive national and international business growth.    
Eduardo Molinari

Eduardo Molinari

Chief Marketing Officer
Mr. Molinari has more than 25 years of experience in the pharmaceutical industry, having held executive leadership positions in countries across Latin America, most recently VP Region North – Latin America of AbbVie until December 2018. In 2012, when Abbott spun out its pharmaceutical business to form AbbVie, Mr. Molinari left Abbott to establish AbbVie in Latin America where he played a key role in the growth of the company in the region. His business expertise is combined with deep experience in R&D both in academia at Northwestern University Medical School in Chicago and in the pharmaceutical industry. Mr. Molinari has shown continued growth as a leader in the industry with a commitment to bringing healthcare solutions to patients globally.